期刊文献+

可溶性人TRAIL分子的制备及其抗肿瘤活性 被引量:4

Production and Antitumor Activity of Soluble Human TRAIL
下载PDF
导出
摘要 The cDNA encoding human TRAIL extracellular region(amino acids 41—281) was amplified by reverse transcription(RT) PCR from total RNA derived from human acute promyelocytic leukemia cell line HL 60. After sequencing, the cDNA was cloned into the vector pQE 80L and transformed into E.coli DH5 α . By IPTG induction, the soluble TRAIL 41—281 (sTRAIL 41—281 ) protein was expressed with the 40% of total bacteria protein. Inclusion bodies were dissolved into 8 mol/L urea, purified by Ni NTA chromatography column, the product with over 90% purity was obtained. After refolding by dialysis, the active trimer form of sTRAIL 41~281 was derived from the renatured proteins by gel filtration chromatography. The MTT assay, flow cytometry and DNA fragmentation assay showed that the refolded sTRAIL 41~281 could potently inhibit the growth of Jurkat cells and induce apoptosis, confirmed the apoptosis inducing activity of sTRAIL 41~281 on tumor cells, it will benefit the further research of TRAIL. The cDNA encoding human TRAIL extracellular region(amino acids 41—281) was amplified by reverse transcription(RT) PCR from total RNA derived from human acute promyelocytic leukemia cell line HL 60. After sequencing, the cDNA was cloned into the vector pQE 80L and transformed into E.coli DH5 α . By IPTG induction, the soluble TRAIL 41—281 (sTRAIL 41—281 ) protein was expressed with the 40% of total bacteria protein. Inclusion bodies were dissolved into 8 mol/L urea, purified by Ni NTA chromatography column, the product with over 90% purity was obtained. After refolding by dialysis, the active trimer form of sTRAIL 41~281 was derived from the renatured proteins by gel filtration chromatography. The MTT assay, flow cytometry and DNA fragmentation assay showed that the refolded sTRAIL 41~281 could potently inhibit the growth of Jurkat cells and induce apoptosis, confirmed the apoptosis inducing activity of sTRAIL 41~281 on tumor cells, it will benefit the further research of TRAIL.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2004年第3期418-422,共5页 Chinese Journal of Biochemistry and Molecular Biology
关键词 TRAIL PURIFICATION REFOLDING ACTIVITY TRAIL, purification, refolding, activity
  • 相关文献

参考文献14

  • 1Wiley S R, Schooley K, Smolak P J, Din W S, Huang C P, Nicholl J K, Sutherland G R, Davis T D, Smith C, Rauch C, Smith C A,Goodwin R G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995, 3(4) :673
  • 2Pitti R M , Marsters S A, Ruppert S, Donahue C J, Moore A,Ashkenazi A. Induction of apoptosis by Apo-2 ligand , a new member of the tumor necrosis factor cytokine family. J Biol Chem, 1996, 271(22): 12687 - 12690
  • 3Pan G H,O' Rourke K , Chinnaiyan A M, Gentz R, Ebner R, Ni J,Dixit V M. The receptor for cytotoxic ligind TRAIL. Science, 1997,276(5306) :lll- 113
  • 4MacFarlane M, Ahmad M, Srinivasula S M, FemandesAlnemri T,Cohen G M, Alnemri E S. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem, 1997,272(41) :25417 ~ 25420
  • 5Degli-Esposti M A, Smolak P J, Walczak H, Waugh J, Huang C P,DuBose R F, Smith C A, Goodwin R G. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med, 1997, 186(7): 1165 ~ 1170
  • 6Emery J G, McDonnell P, Burke M B, Deen K C, Lyn S, Silverman C, Dul E, Appelbaum E R, Eichman C, Diprinzio R, Dodds R A,James I E, Rosenberg M, Lee J C, Young P R. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem, 1998,273(23):14
  • 7Cha S S, Kim M S, Choi Y H, Sung B J, Shin N K, Shin H C, Sung Y C, Oh B H. 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity, 1999,11(2): 253- 261
  • 8Ashkenazi A, Pai R C, Fong S, Leung S, Lawrence D A, Marsters S A, Blackie C, Chang L, McMurtrey A E, Hebert A, DeForge L,Koumenis I L, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall R H. Safety and antitumor activity of recombinant soluble
  • 9Mosmann T. Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. J Immunol Methods,1983,65:55 - 63
  • 10Jo M, Kim T H, Seol D W, Esplen J E, Dorko K, Billiar T R, Strom S C. Apoptosis induced in normal human hepatecytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med, 2000 ,6(5):564 -567

二级参考文献13

  • 1余为明 焦炳华.肿瘤坏死因子及其相关毒素[M].上海:上海科学技术出版社,1991..
  • 2Pan G,Science,1997年,277卷,815页
  • 3余伟明,肿瘤坏死因子及相关细胞毒素,1991年
  • 4Kuang A A,J Biol Chem,2000年,275卷,33期,25065页
  • 5Jo M,Nat Med,2000年,6卷,5期,564页
  • 6Ashkenazi A,J Clin Invest,1999年,104卷,2期,155页
  • 7Hu W H,J Biol Chem,1998年,274卷,43期,30603页
  • 8Griffith T S,J Immunol,1998年,161卷,6期,2833页
  • 9Ye K,Proc Natl Acad Sci USA,1998年,95卷,4期,1601页
  • 10Pan G,Science,1997年,277卷,5306期,111页

共引文献17

同被引文献34

  • 1周建,彭旭东,张健,高小平.重组人TRAIL蛋白的原核表达、纯化及鉴定[J].四川大学学报(自然科学版),2002,39(S1):142-145. 被引量:3
  • 2Xiao-Chao Wei Xin-Juan Wang Kai-Chen Lei Zhang Yu Liang Xin-Li Lin Department of Biochemistry and Molecular Biology,Peking University Health Science Center,Beijing 100083,ChinaProtein Studies,Oklahoma Medical Research Foundation,Oklahoma City,OK 73104,USA.Killing effect of TNF-related apoptosis inducing ligand regulated by tetracycline on gastric cancer cell line NCI-N87[J].World Journal of Gastroenterology,2001,7(4):559-562. 被引量:11
  • 3戴丹菁,谢丛华,张阿丽,邱慧兵,周遵艳.TRAIL联合放射线诱导人脑胶质瘤细胞株U251凋亡的协同作用研究[J].武汉大学学报(医学版),2006,27(6):759-762. 被引量:5
  • 4Ashkenaz A. Directing cancer cells to self-destruct with pro- apoptotic receptor agonists [ J]. Nat Rev Drug Discov, 2008,7 (12) :1001-1012.
  • 5Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induce apoptosis[ J]. Immunity, 1995,3 (6) :6673-682.
  • 6Nagata S. Apoptosis by death factor[J]. Ce11,1997,88(3) :355-365.
  • 7Griffith TS, Stokes B, Kucaba TA, et al. TRAIL gene therapy: From preclinical development to clinical application [ J ]. Curr Gene Ther,2009,9( 1 ) :9 -19.
  • 8Keane MM, Ettenherg SA, Nau MM, et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines [ J ]. Cance Res, 1999,59 (3) :734-741.
  • 9Kruyt F A. TRAIL and cancer therapy[ J]. Cancer Lett,2008,263 (1) :14-25.
  • 10Dohmen R J. SUMO protein modification [ J ]. Biochim Biophys Acta,2004,1695 ( 1-3 ) : 113-131.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部